ANXA10 and hepatocellular carcinoma: This is in agreement with a previous study in hepatocellular carcinoma where ANXA10 and p53 expression revealed significant inverse correlation and down-regulation of ANXA10 and p53 mutation acted synergistically towards poorer prognosis (Liu et al, 2002).